en
Professional article
Open access
English

Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Published inSchweizerische medizinische Wochenschrift, vol. 145, w14100
Publication date2015
Abstract

The availability of drugs such as thalidomide, bortezomib and lenalidomide changed the landscape in myeloma treatment and has extended the median survival up to 10 years with a substantial improvement in quality of life. This development prompted a Swiss expert panel to re-evaluate the current status and formulate updated clinical recommendations for the diagnosis and treatment of plasma cell myeloma. These recommendations should help clinicians in their decision making to achieve the best outcome based on currently available data.

Citation (ISO format)
SAMARAS, Panagiotis et al. Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. In: Schweizerische medizinische Wochenschrift, 2015, vol. 145, p. w14100. doi: 10.4414/smw.2015.14100
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0036-7672
465views
659downloads

Technical informations

Creation11/25/2015 1:44:00 PM
First validation11/25/2015 1:44:00 PM
Update time03/15/2023 12:05:37 AM
Status update03/15/2023 12:05:36 AM
Last indexation01/16/2024 8:06:09 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack